SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001213900-19-009859
Filing Date
2019-05-31
Accepted
2019-05-31 12:17:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sc13d0519novik_enlivextherap.htm SC 13D 37046
  Complete submission text file 0001213900-19-009859.txt   38515
Mailing Address 30 ANMI NAAMIN STREET RAMAT HASHARON L3 47212
Business Address
NOVIK SHAI A (Filed by) CIK: 0001401412 (see all company filings)

Type: SC 13D

Mailing Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042
Business Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042 972 (0) 3 7326616
Enlivex Therapeutics Ltd. (Subject) CIK: 0001596812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88278 | Film No.: 19869416
SIC: 2834 Pharmaceutical Preparations